Embolism: Clinical Trials

7 trials for Embolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 7
Phase 32Terminated 2
Phase 11Terminated 1

Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
Rivaroxaban, Standard Of Care (SOC) - COVID-19
Phase 2TerminatedCharite University, Berlin, Germany1112020-11-302022-01-12
Anticoagulation Length in Cancer Associated Thrombosis
Low Molecular Weight Heparin (LMWH) - Cancer, Thrombosis
Phase 2TerminatedCardiff University22013-12-012018-10-29
Diclofenac for Submassive PE
Diclofenac, Placebo - Pulmonary Embolism
Phase 2 / Phase 3TerminatedMinistry of Health, Spain342012-05-012017-09-06
Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)
prednisone, placebo - Cholesterol Embolism Systemic
Phase 2TerminatedUniversity Hospital, Toulouse392011-06-012016-05-09
Carbon Dioxide Insufflation on Cerebral Microemboli
Carbon dioxide insufflation - Cardiovascular Disease, Mitral Valve Repair
Phase 2 / Phase 3TerminatedUniversity Health Network, Toronto202008-04-012011-10-26
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
Mechanical Thrombectomy - Pulmonary Embolism
Phase 1 / Phase 2TerminatedStraub Medical AG502005-10-012009-08-07
Tenecteplase Pulmonary Embolism Italian Study
tenecteplase - Pulmonary Embolism
Phase 2TerminatedUniversity Of Perugia1802004-07-012008-05-06

Narrower conditions

Pulmonary Embolism (5)  ·  Venous Thromboembolism (2)  ·  Venous Thrombosis (2)  ·  Ventricular Dysfunction, Right (2)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Inflammation (1)  ·  Myocardial Infarction (1)  ·  Neoplasms (1)  ·  Renal Insufficiency (1)  ·  Thrombosis (1)

Broader conditions

Embolism and Thrombosis (7)  ·  Vascular Diseases (7)  ·  Cardiovascular Diseases (6)  ·  Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Heart Diseases (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Thromboembolism (2)  ·  Ventricular Dysfunction (2)  ·  Cognition Disorders (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Female Urogenital Diseases (1)

Interventions

Dalteparin (1)  ·  Diclofenac (1)  ·  Enoxaparin (1)  ·  Heart-Lung Machine (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Oxygenators, Membrane (1)  ·  Prednisone (1)  ·  Rivaroxaban (1)  ·  Standard of Care (1)  ·  Tenecteplase (1)  ·  Tinzaparin (1)  ·  Ultrasonography, Doppler, Transcranial (1)

Sponsors

Cardiff University (1)  ·  Charite University, Berlin, Germany (1)  ·  Ministry of Health, Spain (1)  ·  Straub Medical AG (1)  ·  University Health Network, Toronto (1)  ·  University Hospital, Toulouse (1)  ·  University Of Perugia (1)

Countries

Germany (2)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Antoine Huart, MPD (1)  ·  Cecilia Becattini, MD (1)  ·  David Jimenez, MD, PhD (1)  ·  Dominique Chauveau, PhD (1)  ·  Giancarlo Agnelli, MD (1)  ·  Nils Kucher, MD (1)  ·  Patricia Murphy, BSc, MD, FRCPC (1)  ·  Simon Noble, Dr (1)  ·  Ulf Landmesser, Prof. Dr. (1)

Results publications

PMID 19833379, PMID 26490434, PMID 29247809, PMID 33502773, PMID 35244208